Author's Note: Hydroxychloroquine (Plaquenil), a drug developed to combat the infectious disease malaria, was found by happenstance to be of value in suppressing certain manifestations of SLE (systemic lupus erythematosus), an inflammatory disease, and retains a niche use for that secondary purpose.
Recently, the drug has been advocated, without convincing evidence, to treat the severe lung involvement of COVID-19 pneumonia.
Also, please check out the Lancet's concurrent study on the acute use of antimalarial drugs as published online at https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31180-6/fulltext
Or, check this link to the story in the Washington Post.
Or, check this link to the story in the Washington Post.
You can review these illustrated verses in a wider context by proceeding to 'Pharmaceutical (pill-poppin') Poems' on the full-service blog "Edifying Nonsense". Click HERE.
No comments:
Post a Comment